SCHEMBL6553103

SCHEMBL6553103

Nc1cc(Cl)cc(Cl)c1S(N)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 11/20 0.47
CA2 P00918 11/20 0.47
CA9 Q16790 9/20 0.45
CA12 O43570 4/20 0.45
CA4 P22748 4/20 0.45
CA6 P23280 3/20 0.45
CA5A P35218 3/20 0.45
CA7 P43166 3/20 0.45
CA14 Q9ULX7 3/20 0.45
CA5B Q9Y2D0 3/20 0.45
CA3 P07451 2/20 0.45
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NR3C1 P04150 3/20 0.39
NR3C2 P08235 3/20 0.39
PGR P06401 1/20 0.39
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645227 0.86 CA1 (0.54) CA1CA2CA9CA12CA4
SCHEMBL544443 0.83 CA1 (0.41) CA1CA2CA9CA12CA4
SCHEMBL4637340 0.81 CYP2C9 (0.45) CA1CA2CA9CA12CA4
SCHEMBL10960514 0.78 CA1 (0.57) CA1CA2CA9CA12CA4
SCHEMBL1644207 0.77 CA2 (0.46) CA1CA2CA9CA12CA4
SCHEMBL3489898 0.76 NR3C1 (0.44) CA1CA2CA9CA12CA4
SCHEMBL4381560 0.75 CA1 (0.48) CA1CA2CA9CA12CA4
SCHEMBL3489281 0.72 NR3C1 (0.46) CA1CA2CA9NR3C1NR3C2
SCHEMBL5353941 0.71 TSHR (0.48) CA1CA2CA9CA12CA4
SCHEMBL7952991 0.71 APEX1 (0.67) CA1CA2CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906297-B1 1,2,4-BENZOTHIADIAZINE DERIVATIVES, THEIR PREPARATION AND USE UNIV LIEGE (BE) 2004-02-25 EP disclosed
CN-1081633-C 1,2, 4-benzothiadiazine derivatives, method for preparing same and use thereof NOVO NORDISK AS (DK) 2002-03-27 CN disclosed
US-6242443-B1 1,2,4-benzothiadiazine derivatives, their preparation and use NOVO NORDISK AIS (DK) 2001-06-05 US disclosed
CN-1222910-A 1,2, 4-benzothiadiazine derivatives, method for preparing same and use thereof NOVO NORDISK AS (DK) 1999-07-14 CN disclosed
EP-0906297-A1 1,2,4-BENZOTHIADIAZINE DERIVATIVES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1999-04-07 EP disclosed
WO-1997049692-A1 1,2,4-BENZOTHIADIAZINE DERIVATIVES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1997-12-31 WO disclosed
EP-0719262-A1 3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE-3-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING SAME Aventis Pharma S.A. (FR) 1996-07-03 EP disclosed
WO-1995007899-A1 3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE-3-CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1995-03-23 WO disclosed
EP-0636124-A1 3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE-3-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME Aventis Pharma S.A. (FR) 1995-02-01 EP disclosed
WO-1993021171-A1 USE OF 2H-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE-3-CARBOXYLIC ACID DERIVATIVES FOR PREPARING NMDA/AMPA RECEPTOR ANTAGONIST DRUGS, NOVEL PRODUCTS, PREPARATION THEREOF AND DRUGS CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1993-10-28 WO disclosed
WO-1993021170-A1 3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE-3-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1993-10-28 WO disclosed
US-4556733-A Process for the preparation of 2-hydroxybenzenesulfonamide E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-12-03 US disclosed